Application no. and date | 08848438.1 (espacenet) (Federated) (European Patent Register), 20081103 | Patent/reg. no. and date | DK/EP 2207775, 20120321 | Publication date | 20100721 | Priority no. and date | US 985456 P, 20071105 | EP pub. no. and date |
EP 2207775 20100721 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | 143837 | Inventor | MOGI, Muneto, 70 Hope Avenue, 603
Waltham MA 02453, US, YAMADA, Ken, 4 Emerson Place, 711
Boston MA 02114, US, YASOSHIMA, Kayo, 285 Third street, 415
Cambridge MA 02142, US, KAWANAMI, Toshio, One Emerson Place 16L
Boston MA 02114, US, UMEMURA, Ichiro, Park Hill Azuma 1-401 3-19-1 Azuma Tsukuba-shi
Ibaraki 305-0031, JP, IWAKI, Yuki, 1691 Cambridge Street, 24
Cambridge MA 02138, US, QIN, Hongbo, 1049-7 Nakanojo Sakakimachi
Hanishinagun Nagano 389-0602, JP, IMASE, Hidetomo, 30 Cambridge Park Dr. 4137
Cambridge MA 02140, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/5377 (2006.01) , A61P 3/06 (2006.01) , C07D 401/12 (2006.01) , C07D 401/14 (2006.01) , C07D 413/14 (2006.01) | Title | 4-Benzylamino-1-carboxyacylpiperidinderivater som CETP-inhibitorer, som er anvendelige til behandling af sygdomme som hyperlipidæmi eller arteriosclerose | Int. application no. | EP2008064859 | Int. publication no. | WO2009059943 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|